BODI vs GRPN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 24, 2026

BODI

49.4
AI Score
VS
BODI Wins

GRPN

44.6
AI Score

Investment Advisor Scores

BODI

49score
Recommendation
HOLD

GRPN

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric BODI GRPN Winner
Forward P/E 6.5531 23.9234 BODI
PEG Ratio 0 14.657 Tie
Revenue Growth -22.4% -0.8% GRPN
Earnings Growth 0.0% 109.2% GRPN
Tradestie Score 49.4/100 44.6/100 BODI
Profit Margin 5.7% -25.3% BODI
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

BODI 1M: -15.6% · 3M: -51.4% GRPN 1M: +2.5% · 3M: -27.3%

Current Technical Phase

BODI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -24.8%), weak momentum, RSI 35

RSI (14): 35.2 · Price: $4.92

GRPN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.3%), weak momentum, RSI 45

RSI (14): 44.8 · Price: $19.31

Fundamentals Snapshot

Metric BODI GRPN
Market Cap — —
Forward P/E 54.7 22.5
Trailing P/E 2.6 —
Revenue (TTM) — —
Revenue Growth -0.2% 0.0%
Gross Margin 0.7% 0.9%
Operating Margin 0.0% 0.0%
EPS 1.82 -3.13
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BODI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.